From: CCT8 drives colorectal cancer progression via the RPL4-MDM2-p53 axis and immune modulation
Clinicopathological features | CCT8 expression level | P value | |
---|---|---|---|
Low | High | ||
Age at diagnosis (years) | Â | Â | 0.515a |
 ≥60 | 27 | 61 |  |
 <60 | 13 | 38 |  |
Gender | Â | Â | 0.879a |
 Male | 26 | 63 |  |
 Female | 14 | 36 |  |
Tumor location | Â | Â | 0.554a |
 Colon | 14 | 40 |  |
 Rectum | 26 | 59 |  |
Tumor size (cm) | Â | Â | 0.402a |
 >5 | 6 | 21 |  |
 ≤5 | 34 | 78 |  |
Histological grade |  |  | < 0.001a |
 Low | 13 | 82 |  |
 High | 27 | 17 |  |
Metastasis | Â | Â | 0.001a |
 Yes | 9 | 52 |  |
 No | 31 | 47 |  |
TMN stage | Â | Â | 0.001a |
 I-II | 31 | 47 |  |
 III-IV | 9 | 52 |  |
Mean survival time (months) | 48.55 | 35.48 | 0.046b |